Daré Bioscience, Inc. Announces Licensing and Global Rights to Novel Phase III Product Candidate for the Treatment of Bacterial Vaginosis

Stock Information for Dare Bioscience Inc.

Loading

Please wait while we load your information from QuoteMedia.